S 4667 United States Senate · 118th Congress

Risky Research Review Act

The Risky Research Review Act establishes a new Life Sciences Research Security Board to review Federal funding for certain high-risk life sciences research before it's approved. The Board, composed of 9 appointed members including scientists and national security experts, will determine whether agencies can fund research that could pose threats to public health, safety, or national security. Entities seeking funding must attest whether their research qualifies as "high-risk" and disclose work with select agents or toxins, with the Board having 120 days to review high-risk proposals and set minimum biosafety and biosecurity requirements. The bill authorizes $30 million annually for the Board's operations from the Department of Homeland Security. This review process will apply to research involving potential pandemic pathogens, gain of function research, or dual-use applications with significant potential for misuse.
Bill status in committee 1 of 4 stages cleared
Introduction
Jul 2024
Committee Review
Floor Vote
President
Introduced Jul 10, 2024 Last action Dec 5, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
6
Key actions
3
Committee
4
Dec 5, 2024
Upper · Passed
Committee on Homeland Security and Governmental Affairs. Reported by Senator Peters with an amendment in the nature of a substitute. With written report No. 118-264.
upper
Sep 25, 2024
Upper · Passed
Committee on Homeland Security and Governmental Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
upper
Jul 11, 2024
Upper · Passed
Committee on Homeland Security and Governmental Affairs. Hearings held.
upper
Jul 10, 2024
Committee
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
upper
Jul 10, 2024
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor

Sponsors